UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 243

Sortiert nach

Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review

International journal of molecular sciences, 2021-05, Vol.22 (11), p.5801

2021

Link zum Volltext

Verfügbarkeit prüfen

MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review

Cancers, 2021-01, Vol.13 (3), p.514

2021

Link zum Volltext

Verfügbarkeit prüfen

Antitumor Effect of Zinc Acetate in Hepatocellular Carcinoma Cell Lines via the Induction of Apoptosis

Journal of Nutritional Science and Vitaminology, 2022/08/31, Vol.68(4), pp.303-311

2022

Link zum Volltext

Verfügbarkeit prüfen

Can microRNA‐96‐5p serve as a therapeutic molecule in the near future?

Hepatology research, 2022-01, Vol.52 (1), p.3-4

2022

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA Interference in Hepatic Host-Pathogen Interactions

International journal of molecular sciences, 2021-03, Vol.22 (7), p.3554

2021

Link zum Volltext

Verfügbarkeit prüfen

Albumin platelet product as a novel score for liver fibrosis stage and prognosis

Scientific reports, 2021-03, Vol.11 (1), p.5345-5345, Article 5345

2021

Link zum Volltext

Verfügbarkeit prüfen

Sequential therapy including regorafenib for unresectable hepatocellular carcinoma: Effect of early relative changes in hepatic functional reserve after regorafenib administration on prognosis

Hepatology research, 2021-12, Vol.51 (12), p.1219-1228

2021

Link zum Volltext

Verfügbarkeit prüfen

The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo

Molecular cancer therapeutics, 2012-03, Vol.11 (3), p.549-560

2012

Link zum Volltext

Verfügbarkeit prüfen

MicroRNAs and Nonalcoholic Steatohepatitis: A Review

International journal of molecular sciences, 2023-10, Vol.24 (19), p.14482

2023

Link zum Volltext

Verfügbarkeit prüfen

Shorter pruritus period and milder disease stage are associated with response to nalfurafine hydrochloride in patients with chronic liver disease

Scientific reports, 2022-05, Vol.12 (1), p.7311-7311, Article 7311

2022

Link zum Volltext

Verfügbarkeit prüfen

Galectin-9 in Gastroenterological Cancer

International journal of molecular sciences, 2023-03, Vol.24 (7), p.6174

2023

Link zum Volltext

Verfügbarkeit prüfen

Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model

PloS one, 2022-02, Vol.17 (2), p.e0261310-e0261310

2022

Link zum Volltext

Verfügbarkeit prüfen

Diabetes mellitus and metformin in hepatocellular carcinoma

World journal of gastroenterology : WJG, 2016-07, Vol.22 (27), p.6100-6113

2016

Link zum Volltext

Verfügbarkeit prüfen

Ledipasvir/Sofosbuvir Is Effective for Relapsed Genotype 1b Hepatitis C Virus Patients after Achieving a Sustained Virological Response at Post-treatment Week 12 with Glecaprevir/Pibrentasvir

Internal Medicine, 2023/09/01, Vol.62(17), pp.2507-2511

2023

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child‐Pugh class A or B liver function in real‐world clinical practice

Hepatology research, 2022-09, Vol.52 (9), p.773-783

2022

Link zum Volltext

Verfügbarkeit prüfen

Evaluating the Effect of Lenvatinib on Sorafenib-Resistant Hepatocellular Carcinoma Cells

International journal of molecular sciences, 2021-12, Vol.22 (23), p.13071

2021

Link zum Volltext

Verfügbarkeit prüfen

Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma

American journal of physiology: Gastrointestinal and liver physiology, 2020-03, Vol.318 (3), p.G401-G409

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparison of therapeutic outcomes of sorafenib and lenvatinib as primary treatments for hepatocellular carcinoma with a focus on molecular‐targeted agent sequential therapy: A propensity score‐matched analysis

Hepatology research, 2021-04, Vol.51 (4), p.472-481

2021

Link zum Volltext

Verfügbarkeit prüfen

Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients

BMC gastroenterology, 2024-04, Vol.24 (1), p.123-123

2024

Link zum Volltext

Verfügbarkeit prüfen

Cancer Therapy Due to Apoptosis: Galectin-9

International journal of molecular sciences, 2017-01, Vol.18 (1), p.74-74

2017

Link zum Volltext

Verfügbarkeit prüfen

Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective study

Hepatology international, 2022-10, Vol.16 (5), p.1150-1160

2022

Link zum Volltext

Verfügbarkeit prüfen

Peg-IFNα-2a Contributed to HBs Antigen Seroclearance in a Patient with Chronic Hepatitis B Administered Nucleic Acid Analogs: A Three-year Follow-up

Internal Medicine, 2021/06/15, Vol.60(12), pp.1835-1838

2021

Link zum Volltext

Verfügbarkeit prüfen

Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study

Hepatology international, 2023-06, Vol.17 (3), p.606-614

2023

Link zum Volltext

Verfügbarkeit prüfen

Antitumor Effect of Regorafenib on MicroRNA Expression in Hepatocellular Carcinoma Cell Lines

International journal of molecular sciences, 2022-01, Vol.23 (3), p.1667

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of modified albumin–bilirubin grade on survival in patients with HCC who received lenvatinib

Scientific reports, 2021-07, Vol.11 (1), p.14474-14474, Article 14474

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 243

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(205)
Mit Volltextzugriff
(234)

Publikationsform

Sprache

Englisch
(223)
Japanisch
(64)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review

MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review

Antitumor Effect of Zinc Acetate in Hepatocellular Carcinoma Cell Lines via the Induction of Apoptosis

Can microRNA‐96‐5p serve as a therapeutic molecule in the near future?

MicroRNA Interference in Hepatic Host-Pathogen Interactions

Albumin platelet product as a novel score for liver fibrosis stage and prognosis

Sequential therapy including regorafenib for unresectable hepatocellular carcinoma: Effect of early relative changes in hepatic functional reserve after regorafenib administration on prognosis

The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo

MicroRNAs and Nonalcoholic Steatohepatitis: A Review

Shorter pruritus period and milder disease stage are associated with response to nalfurafine hydrochloride in patients with chronic liver disease

Galectin-9 in Gastroenterological Cancer

Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model

Diabetes mellitus and metformin in hepatocellular carcinoma

Ledipasvir/Sofosbuvir Is Effective for Relapsed Genotype 1b Hepatitis C Virus Patients after Achieving a Sustained Virological Response at Post-treatment Week 12 with Glecaprevir/Pibrentasvir

Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child‐Pugh class A or B liver function in real‐world clinical practice

Evaluating the Effect of Lenvatinib on Sorafenib-Resistant Hepatocellular Carcinoma Cells

Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma

Comparison of therapeutic outcomes of sorafenib and lenvatinib as primary treatments for hepatocellular carcinoma with a focus on molecular‐targeted agent sequential therapy: A propensity score‐matched analysis

Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients

Cancer Therapy Due to Apoptosis: Galectin-9

Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective study

Peg-IFNα-2a Contributed to HBs Antigen Seroclearance in a Patient with Chronic Hepatitis B Administered Nucleic Acid Analogs: A Three-year Follow-up

Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study

Antitumor Effect of Regorafenib on MicroRNA Expression in Hepatocellular Carcinoma Cell Lines

Impact of modified albumin–bilirubin grade on survival in patients with HCC who received lenvatinib

Suchergebnisse filtern